Activated osteoarthritis following immune checkpoint inhibitor treatment: an observational study

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy but can result in toxicities, known as immune-related adverse events (irAEs), due to a hyperactivated immune system. ICI-related inflammatory arthritis has been described in literature, but herewith we introduce and characterize...

Descripción completa

Detalles Bibliográficos
Autores principales: Reid, Pankti, Liew, David FL, Akruwala, Rajshi, Bass, Anne R, Chan, Karmela K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444247/
https://www.ncbi.nlm.nih.gov/pubmed/34526389
http://dx.doi.org/10.1136/jitc-2021-003260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444247/
https://www.ncbi.nlm.nih.gov/pubmed/34526389
http://dx.doi.org/10.1136/jitc-2021-003260

Ejemplares similares